FLUIDIA
FLUIDIA is a start-up that develops and commercializes a new generation of molecular tests to diagnose different types of diseases. The new technology that FLUIDIA has developed and patented makes it possible to evaluate the shape of any biomarker protein quickly and economically. The start-up has applied this innovative technology to a biomarker common to the main cancers, thus making it possible to develop an early detection test that will be introduced on the market in 2020.
Website : www.fluidiabiotech.com